var singsData = [{"date":new Date(2012,1,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.81","showOnAxis":true},{"date":new Date(2012,1,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades CVX to Buy from Hold. Target Price is $130; previously $115.","showOnAxis":false},{"date":new Date(2012,10,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.9","showOnAxis":true},{"date":new Date(2012,10,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,10,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2012 Q3's earning $2.69 per share and revenue $56000MM. This misses analyst's estimated EPS $2.83, misses estimated revenue $64090MM.","showOnAxis":false},{"date":new Date(2012,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CVX to Buy. Target Price is $120; previously $125.","showOnAxis":true},{"date":new Date(2012,11,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,11,6),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Dahlman Rose upgrades CVX to Buy from Hold. Target Price is $120.","showOnAxis":false},{"date":new Date(2012,11,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $130.","showOnAxis":true},{"date":new Date(2012,2,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,2,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,2,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CVX to Overweight. Target Price is $126; previously $137.","showOnAxis":true},{"date":new Date(2012,3,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CVX to Buy. Target Price is $126; previously $124.","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2012 Q1's earning $3.27 per share and revenue $58896MM..","showOnAxis":false},{"date":new Date(2012,3,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,4,16),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.9","showOnAxis":true},{"date":new Date(2012,4,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains CVX to Outperform. Target Price is $120; previously $130.","showOnAxis":true},{"date":new Date(2012,6,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CVX to Buy. Target Price is $120; previously $126.","showOnAxis":true},{"date":new Date(2012,6,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades CVX to Neutral from Underweight. Target Price is $120.","showOnAxis":false},{"date":new Date(2012,6,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,27),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2012 Q2's earning $3.56 per share and revenue $60000MM. This beats analyst's estimated EPS $3.24, misses estimated revenue $68560MM.","showOnAxis":false},{"date":new Date(2012,7,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.9","showOnAxis":true},{"date":new Date(2012,7,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $120.","showOnAxis":true},{"date":new Date(2012,8,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Outperform. Target Price is $135; previously $120.","showOnAxis":true},{"date":new Date(2012,8,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CVX to Neutral. Target Price is $123; previously $120.","showOnAxis":true},{"date":new Date(2012,8,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Scotia Howard Weil upgrades CVX to Market Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2012,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"VTB Capital initiates coverage on CVX to Hold. Target Price is $120.","showOnAxis":true},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CVX to Neutral. Target Price is $125; previously $110.","showOnAxis":true},{"date":new Date(2012,9,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Dahlman Rose initiates coverage on CVX to Hold.","showOnAxis":true},{"date":new Date(2012,9,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale maintains CVX to Buy. Target Price is $130; previously $131.","showOnAxis":true},{"date":new Date(2012,9,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,9,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,9,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,0,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,0,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oracle Investment Research downgrades CVX to Hold from Buy. Target Price is $110.","showOnAxis":true},{"date":new Date(2013,1,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale downgrades CVX to Hold from Buy. Target Price is $126.","showOnAxis":true},{"date":new Date(2013,1,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.9","showOnAxis":true},{"date":new Date(2013,1,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Canaccord Genuity initiates coverage on CVX to Buy. Target Price is $136.","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,1,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Dahlman Rose maintains CVX to Buy. Target Price is $129; previously $120.","showOnAxis":true},{"date":new Date(2013,1,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades CVX to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,10,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1","showOnAxis":true},{"date":new Date(2013,10,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Outperform. Target Price is $140; previously $135.","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital initiates coverage on CVX to Sector Perform. Target Price is $120.","showOnAxis":true},{"date":new Date(2013,11,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC initiates coverage on CVX to Overweight. Target Price is $138.","showOnAxis":true},{"date":new Date(2013,2,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CVX to Neutral. Target Price is $130; previously $125.","showOnAxis":true},{"date":new Date(2013,2,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cowen & Co. maintains CVX to Buy. Target Price is $133; previously $129.","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,2,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,3,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains CVX to Overweight. Target Price is $135; previously $130.","showOnAxis":true},{"date":new Date(2013,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CVX to Buy. Target Price is $135; previously $125.","showOnAxis":true},{"date":new Date(2013,3,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,3,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2013 Q1's earning $3.18 per share and revenue $54296MM. This beats analyst's estimated EPS $3.06.","showOnAxis":false},{"date":new Date(2013,4,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2013,4,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,5,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies downgrades CVX to Hold from Buy.","showOnAxis":true},{"date":new Date(2013,5,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo initiates coverage on CVX to Outperform.","showOnAxis":true},{"date":new Date(2013,5,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,5,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2013,5,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays downgrades CVX to Equal-Weight from Overweight. Target Price is $145; previously $133.","showOnAxis":true},{"date":new Date(2013,6,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1","showOnAxis":true},{"date":new Date(2013,7,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2013 Q2's earning $2.77 per share and revenue $55307MM. This misses analyst's estimated EPS $2.98, misses estimated revenue $56010MM.","showOnAxis":false},{"date":new Date(2013,9,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,0,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,0,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,0,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,0,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"S&P Capital IQ downgrades CVX to Buy from Strong Buy.","showOnAxis":true},{"date":new Date(2014,0,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Scotia Howard Weil downgrades CVX to Sector Perform from Sector Outperform.","showOnAxis":true},{"date":new Date(2014,0,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1","showOnAxis":true},{"date":new Date(2014,10,14),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2014,10,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,10,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades CVX to Outperform from Strong Buy. Target Price is $140.","showOnAxis":true},{"date":new Date(2014,10,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CVX to Neutral. Target Price is $126; previously $130.","showOnAxis":true},{"date":new Date(2014,11,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CVX to Buy. Target Price is $125; previously $141.","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,11,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains CVX to Outperform. Target Price is $130; previously $140.","showOnAxis":true},{"date":new Date(2014,2,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,3,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital initiates coverage on CVX to Market Perform. Target Price is $125.","showOnAxis":true},{"date":new Date(2014,3,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies initiates coverage on CVX to Buy. Target Price is $140.","showOnAxis":true},{"date":new Date(2014,3,9),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Argus Research downgrades CVX to Hold from Buy. Target Price is $130.","showOnAxis":true},{"date":new Date(2014,5,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on CVX to Buy. Target Price is $142.","showOnAxis":true},{"date":new Date(2014,6,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CVX to Buy. Target Price is $157; previously $142.","showOnAxis":true},{"date":new Date(2014,6,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $141; previously $130.","showOnAxis":true},{"date":new Date(2014,7,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,7,14),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,7,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2014,7,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades CVX to Equal-Weight from Overweight.","showOnAxis":true},{"date":new Date(2014,8,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan initiates coverage on CVX to Neutral. Target Price is $133.","showOnAxis":true},{"date":new Date(2014,8,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America downgrades CVX to Underperform from Neutral. Target Price is $133; previously $135.","showOnAxis":true},{"date":new Date(2014,9,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CVX to Buy. Target Price is $138; previously $140.","showOnAxis":true},{"date":new Date(2014,9,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,0,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $141.","showOnAxis":true},{"date":new Date(2015,0,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CVX to Buy. Target Price is $125; previously $129.","showOnAxis":true},{"date":new Date(2015,0,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo downgrades CVX to Market Perform.","showOnAxis":true},{"date":new Date(2015,0,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades CVX to Neutral from Outperform.","showOnAxis":true},{"date":new Date(2015,0,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,0,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,0,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup downgrades CVX to Neutral from Buy. Target Price is $115; previously $125.","showOnAxis":true},{"date":new Date(2015,1,12),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2015,1,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CVX to Neutral. Target Price is $111; previously $118.","showOnAxis":true},{"date":new Date(2015,1,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer downgrades CVX to Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,10,16),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2015,10,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,10,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Neutral. Target Price is $100; previously $87.","showOnAxis":true},{"date":new Date(2015,10,3),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Evercore ISI Group upgrades CVX to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,11,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CVX to Overweight. Target Price is $91; previously $94.","showOnAxis":true},{"date":new Date(2015,11,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Argus Research upgrades CVX to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,11,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades CVX to Buy from Neutral. Target Price is $110; previously $95.","showOnAxis":false},{"date":new Date(2015,2,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,2,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,2,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs initiates coverage on CVX to Neutral. Target Price is $110.","showOnAxis":true},{"date":new Date(2015,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,15),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2015,4,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades CVX to Sell from Neutral. Target Price is $99; previously $111.","showOnAxis":true},{"date":new Date(2015,4,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CVX to Neutral. Target Price is $114; previously $116.","showOnAxis":true},{"date":new Date(2015,4,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $115; previously $110.","showOnAxis":true},{"date":new Date(2015,5,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CVX to Buy. Target Price is $125; previously $120.","showOnAxis":true},{"date":new Date(2015,5,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Societe Generale upgrades CVX to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,6,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $110; previously $115.","showOnAxis":true},{"date":new Date(2015,7,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2015,7,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CVX to Neutral from Underperform. Target Price is $100; previously $104.","showOnAxis":false},{"date":new Date(2015,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $99; previously $110.","showOnAxis":true},{"date":new Date(2015,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CVX to Neutral. Target Price is $95; previously $104.","showOnAxis":true},{"date":new Date(2015,7,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","showOnAxis":true},{"date":new Date(2015,7,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains CVX to Sector Perform. Target Price is $101; previously $102.","showOnAxis":true},{"date":new Date(2015,8,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades CVX to Overweight from Neutral. Target Price is $86; previously $90.","showOnAxis":false},{"date":new Date(2015,8,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on CVX to Underperform. Target Price is $65.","showOnAxis":true},{"date":new Date(2015,8,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wolfe Research upgrades CVX to Peer Perform from Underperform.","showOnAxis":false},{"date":new Date(2015,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,8,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Neutral. Target Price is $87; previously $110.","showOnAxis":true},{"date":new Date(2015,9,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $96; previously $99.","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2015 Q3's earning $1.09 per share and revenue $34315MM. This beats analyst's estimated EPS $0.78, beats estimated revenue $29880MM.","showOnAxis":false},{"date":new Date(2016,0,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird initiates coverage on CVX to Outperform. Target Price is $108.","showOnAxis":true},{"date":new Date(2016,0,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,0,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CVX to Buy. Target Price is $103; previously $106.","showOnAxis":true},{"date":new Date(2016,1,16),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2016,10,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades CVX to Overweight from Equal-Weight.","showOnAxis":false},{"date":new Date(2016,10,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"CLSA upgrades CVX to Buy from Outperform.","showOnAxis":false},{"date":new Date(2016,10,16),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.08","showOnAxis":true},{"date":new Date(2016,11,1),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Independent Research upgrades CVX to Buy from Hold.","showOnAxis":false},{"date":new Date(2016,11,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades CVX to Outperform. Target Price is $130; previously $90.","showOnAxis":false},{"date":new Date(2016,2,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CVX to Neutral from Sell.","showOnAxis":false},{"date":new Date(2016,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains CVX to Neutral. Target Price is $96; previously $94.","showOnAxis":true},{"date":new Date(2016,2,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura initiates coverage on CVX to Neutral. Target Price is $85.","showOnAxis":true},{"date":new Date(2016,2,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades CVX to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2016,2,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,2,9),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wolfe Research upgrades CVX to Outperform from Peer Perform.","showOnAxis":false},{"date":new Date(2016,2,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CVX to Neutral. Target Price is $96; previously $84.","showOnAxis":true},{"date":new Date(2016,2,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains CVX to Sector Perform. Target Price is $90; previously $84.","showOnAxis":true},{"date":new Date(2016,3,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,3,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,3,29),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2016 Q1's earning $-0.39 per share and revenue $23553MM. This misses analyst's estimated EPS $-0.1, beats estimated revenue $22210MM.","showOnAxis":false},{"date":new Date(2016,3,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CVX to Equal-Weight. Target Price is $97; previously $89.","showOnAxis":true},{"date":new Date(2016,4,16),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,4,16),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2016,4,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2016,4,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,6,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CVX to Buy. Target Price is $116; previously $114.","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2016 Q2's earning $0.49 per share and revenue $29282MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $28540MM.","showOnAxis":false},{"date":new Date(2016,7,17),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.07","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,7,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,7,9),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"PiperJaffray upgrades CVX to Overweight from Neutral.","showOnAxis":false},{"date":new Date(2016,8,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital initiates coverage on CVX to Outperform. Target Price is $120.","showOnAxis":true},{"date":new Date(2016,9,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,9,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,9,28),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2016 Q3's earning $0.68 per share and revenue $30140MM. This beats analyst's estimated EPS $0.45, beats estimated revenue $29050MM.","showOnAxis":false},{"date":new Date(2016,9,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CVX to Buy from Neutral.","showOnAxis":false},{"date":new Date(2017,0,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"HSBC downgrades CVX to Hold from Buy.","showOnAxis":true},{"date":new Date(2017,0,27),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CVX reports 2016 Q4's earning $0.22 per share and revenue $31497MM. This misses analyst's estimated EPS $0.66, misses estimated revenue $33850MM.","showOnAxis":false},{"date":new Date(2017,0,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bank of America upgrades CVX to Buy from Neutral.","showOnAxis":false}];